RA
ATNM icon

Royce & Associates’s Actinium Pharmaceuticals ATNM Stock Holding History

Royce & Associates’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50,000
Closed -$94K – 838
2024
Q3 		$94K Hold
50,000
– – ﹤0.01% 846
2024
Q2 		$370K Hold
50,000
– – ﹤0.01% 810
2024
Q1 		$392K Hold
50,000
– – ﹤0.01% 805
2023
Q4 		$254K Hold
50,000
– – ﹤0.01% 831
2023
Q3 		$296K Hold
50,000
– – ﹤0.01% 850
2023
Q2 		$371K Hold
50,000
– – ﹤0.01% 859
2023
Q1 		$473K Buy
+50,000
New +$528K ﹤0.01% 843

Other funds holding ATNM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return